Improved interpretation and clinical validation of substitutions in HIV-1 protease predicting the virological response to darunavir/ritonavir

被引:0
|
作者
De Luca, A. [1 ]
Di Giambenedetto, S. [1 ]
Marando, F. [2 ]
Maserati, R. [3 ]
Gianotti, N. [4 ]
Narciso, P. [5 ]
Antinori, A. [5 ]
Di Perri, G. [6 ]
Baldanti, F. [3 ]
Zazzi, M. [7 ]
Perno, C. F. [2 ]
Santoro, M. M. [2 ]
机构
[1] Catholic Univ, Rome, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Policlin San Matteo IRCCS, Pavia, Italy
[4] Hosp San Raffaele, I-20132 Milan, Italy
[5] IRCCS, Natl Inst Infect Dis L Spallanzani, Rome, Italy
[6] Univ Turin, Turin, Italy
[7] Univ Siena, I-53100 Siena, Italy
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:A104 / A104
页数:1
相关论文
共 50 条
  • [41] Design, Synthesis, and Biological Evaluation of Darunavir Analogs as HIV-1 Protease Inhibitors
    Rehman, Muhammad Asad Ur
    Chuntakaruk, Hathaichanok
    Amphan, Soraat
    Suroengrit, Aphinya
    Hengphasatporn, Kowit
    Shigeta, Yasuteru
    Rungrotmongkol, Thanyada
    Krusong, Kuakarun
    Boonyasuppayakorn, Siwaporn
    Aonbangkhen, Chanat
    Khotavivattana, Tanatorn
    ACS BIO & MED CHEM AU, 2024, 4 (05): : 242 - 256
  • [42] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
    Lambert-Niclot, Sidonie
    Flandre, Philippe
    Malet, Isabelle
    Canestri, Ana
    Soulie, Cathia
    Tubiana, Roland
    Brunet, Christel
    Wirden, Marc
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 905 - 908
  • [44] Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes
    De Luca, A
    Vendittelli, M
    Boldini, F
    Di Giambenedetto, S
    Trotta, MP
    Cingolani, A
    Bacarelli, A
    Gori, C
    Perno, CF
    Antinori, A
    Ulivi, G
    ANTIVIRAL THERAPY, 2004, 9 (04) : 583 - 593
  • [45] Improved weighted darunavir genotypic mutation score predicting treatment response for HIV-1 subtype B and non-B infected patients receiving darunavir in a salvage regimen
    De Luca, A.
    Flandre, P.
    Castagna, A.
    Ceccherini-Silberstein, F.
    Cozzi-Lepri, A.
    Churchill, D.
    De Wit, S.
    Dunn, D.
    Fuchs, W.
    Garcia, F.
    Guenthard, H.
    Imaz, A.
    Kordossis, T.
    Mussini, C.
    Obel, N.
    Roca, B.
    Santoro, M. M.
    Schuelter, E.
    Torti, C.
    van Sighem, A.
    Wensing, A. M.
    Wittkop, L.
    Zangerle, R.
    Zazzi, M.
    Descamps, D.
    ANTIVIRAL THERAPY, 2014, 19 : A142 - A142
  • [46] Comparative Cost-Efficacy Analysis of Darunavir/ritonavir and Other Ritonavir-Boosted Protease Inhibitors for First-Line Treatment of HIV-1 Infection in the United States
    Brogan, Anita J.
    Mrus, Joseph
    Hill, Andrew
    Sawyer, Anthony W.
    Smets, Erik
    HIV CLINICAL TRIALS, 2010, 11 (03): : 133 - 144
  • [47] VIROLOGICAL PARAMETERS AS SURROGATE MARKERS FOR CLINICAL OUTCOME IN HIV-1 DISEASE - VERIFICATION, VARIATION, AND VALIDATION
    REICHELDERFER, PS
    COOMBS, RW
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : S19 - S24
  • [48] Low Rate of Virological Failure and Maintenance of Susceptibility to HIV-1 Protease Inhibitors With First-Line Lopinavir/Ritonavir-Based Antiretroviral Treatment in Clinical Practice
    Prosperi, Mattia C. F.
    Zazzi, Maurizio
    Punzi, Grazia
    Monno, Laura
    Colao, Grazia
    Corsi, Paola
    Di Giambenedetto, Simona
    Meini, Genny
    Ghisetti, Valeria
    Bonora, Stefano
    Pecorari, Monica
    Gismondo, Maria Rita
    Bagnarelli, Patrizia
    Carli, Tiziana
    De Luca, Andrea
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (12) : 1996 - 2003
  • [49] Structure-function studies of HIV-1 protease drug resistance to tipranavir and darunavir
    Kovari, L. C.
    Wang, Y.
    Brunzelle, J.
    ANTIVIRAL THERAPY, 2011, 16 : A61 - A61
  • [50] Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance
    Nakashima, Masaaki
    Ode, Hirotaka
    Suzuki, Koji
    Fujino, Masayuki
    Maejima, Masami
    Kimura, Yuki
    Masaoka, Takashi
    Hattori, Junko
    Matsuda, Masakazu
    Hachiya, Atsuko
    Yokomaku, Yoshiyuki
    Suzuki, Atsuo
    Watanabe, Nobuhisa
    Sugiura, Wataru
    Iwatani, Yasumasa
    FRONTIERS IN MICROBIOLOGY, 2016, 7